CSTONE PHARMA-B: (I) GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME; AND (II) GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP
CSTONE PHARMA-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES THE FIFTH INDICATION APPROVED FOR SUGEMALIMAB IN CHINA AS FIRST-LINE TREATMENT OF GASTRIC CANCER
CSTONE PHARMA-B: DATE OF BOARD MEETING
CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT
CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024
CSTONE PHARMA-B: LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
CSTONE PHARMA-B: LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
CSTONE PHARMA-B: POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 17, 2024
CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023
CSTONE PHARMA-B: FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING
CSTONE PHARMA-B: NOTICE OF EXTRAORDINARY GENERAL MEETING
CSTONE PHARMA-B: (1) PROPOSED GRANT OF OPTIONS TO A DIRECTOR AND CHIEF EXECUTIVE OFFICER UNDER THE POST-IPO ESOP; (2) NOTICE OF EXTRAORDINARY GENERAL MEETING; AND (3) CLOSURE OF REGISTER OF MEMBERS FOR THE EXTRAORDINARY GENERAL MEETING
CSTONE PHARMA-B: BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING
CSTONE PHARMA-B: DISCLOSEABLE TRANSACTION IN RELATION TO THE ASSET PURCHASE AGREEMENT
CSTONE PHARMA-B: INSIDE INFORMATION ANNOUNCEMENT - LATEST BUSINESS UPDATE
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES INCLUSION OF AYVAKIT (AVAPRITINIB) IN 2023 CHINA''S NATIONAL REIMBURSEMENT DRUG LIST
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES NMPA APPROVAL OF SUGEMALIMAB AS FIRST-LINE TREATMENT FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA
CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
No Data